Skip to product information
1 of 1

ABCbiolab

SKU:ABCC26132

ELISA Kit for Programmed Cell Death Protein 1 Ligand 2 (PDL2)

ELISA Kit for Programmed Cell Death Protein 1 Ligand 2 (PDL2)

Regular price $630.00 USD
Regular price Sale price $630.00 USD
Sale Sold out
Shipping calculated at checkout.
UOM
Sensitivity
Host

Format

48T, 96T, 96T×5, 96T×10, 96T×100

Detection range

0.156-10ng/mL

Application

Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species

Homo sapiens (Human)

Sensitivity

The minimum detectable dose of this kit is typically less than 0.061ng/mL

Sample type

Tissue homogenates, cell lysates, cell culture supernates and other biological fluids

Assay length

3h

Method

Double-antibody Sandwich

Test principle

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Programmed Cell Death Protein 1 Ligand 2 (PDL2). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Programmed Cell Death Protein 1 Ligand 2 (PDL2). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Programmed Cell Death Protein 1 Ligand 2 (PDL2), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Programmed Cell Death Protein 1 Ligand 2 (PDL2) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Alternative Names

CD273; B7DC; Btdc; PD-L2; PDCD1-L2; PDCD1LG2

Item Name

Programmed Cell Death Protein 1 Ligand 2

Research Area

Signal transduction;Tumor immunity;Infection immunity;Immune molecule;Autoimmunity;

Reference

Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome;

View full details